OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
January 11, 2023
Messenger RNA is inherently unstable and thus requires unique solutions to protect its cohesion.
December 14, 2022
Deeper biological understanding and technology innovations have improved the fate of ADC development.
September 14, 2022
A thorough understanding of both regulatory requirements and study challenges can help develop and validate the appropriate methods for a bioanalytical study program.
August 10, 2022
The clinical trial research environment has evolved because of specific solutions designed to overcome uncertainty.
August 04, 2022
Synthego has launched new engineered cell libraries to validate targets for quicker drug discovery timelines.
August 02, 2022
The growth in demand of viral-vector-based gene therapies drives continuous efforts to improve viral vector manufacturing.
July 13, 2022
Avoiding roadblocks through strategic planning early on can help facilitate IND application filings.
The recent approvals of bispecific antibodies have opened the gate for the further development of these complex molecules.
July 08, 2022
VeriSIM Life and Mayo Clinic are collaborating to develop new promising drug candidates.
LG Chem has decided to proceed with IND-enabling studies and has renewed a license with Avacta.